Read More 5 minute read Pharma Industry News AstraZeneca (LSE: AZN) goes big on U.S. supply chain with latest $2bn manufacturing push AstraZeneca invests $2B in Maryland to expand biologics and rare disease drug manufacturing. Find out what this means for U.S. jobs and the pharma supply chain. bySrinathNovember 25, 2025